A Team of Experts
Our advisory boards are made up of scientists, clinicians, and other specialists with experience in studying and treating desmoid tumors or an expertise in oncology and related fields. Our advisors are critical to our key programs and moving forward in our mission.
Get to know our Medical Advisory Board and Scientific Advisory Board below.
Medical Advisory Board
Aaron Weiss, DO
Associate Professor of Pediatrics, Maine Medical Center
Chair, The DTRF Medical Advisory Board
Rashmi Chugh, MD
Professor of Internal Medicine in the Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Rogel Comprehensive Cancer Center
Gregory Cote, MD, PhD
Medical Oncologist, Massachusetts General Hospital Cancer Center
Fahima Dossa, MD, PhD, FRCSC
Assistant Professor of Surgery, Cedars-Sinai Medical Center
Eldad Elnekave, MD
Consultant interventional radiologist practicing clinically in Israel and the United States
Mrinal Gounder, MD
Associate Professor and Medical Oncologist, Memorial Sloan Kettering Cancer Center
Candace L. Haddox, MD
Medical Oncologist, Dana-Farber Cancer Institute
Peter Hohenberger, MD, PhD
Professor of Surgical Oncology, Mannheim University Medical Center, University of Heidelberg
Bernd Kasper, MD, PhD
Professor, Mannheim University Medical Center, Interdisciplinary Tumor Center, Sarcoma Unit
Robert Lefkowitz, MD
Associate Professor, Radiology, Weill Cornell Medical College/Memorial Sloan-Kettering Cancer Center
Herbert H. Loong, MBBS, FRCP, FHKAM, FASCO
Clinical Associate Professor, Dept. of Clinical Oncology & Medical Director (Oncology), Phase 1 Clinical Trials Centre, The Chinese University of Hong Kong
Christian Meyer, MD, PhD
Instructor of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Fariba Navid, MD
Professor of Clinical Pediatrics, Division of Hematology and Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles Keck School of Medicine, University of Southern California
Seth Pollack, MD
Director of the Sarcoma Program, Lurie Cancer Center, Northwestern University
Raphael E. Pollock, MD, PhD
Director, The Ohio State University Comprehensive Cancer Center
Sameer Rastogi, MD
Professor, Department of Medical Oncology, AIIMS, New Delhi
Chandrajit P. Raut, MD, M.Sc.
Director, Surgical Oncology, Sarcoma, Associate Professor of Surgery, Harvard Medical School
Vinod Ravi, MD
Associate Professor, Vascular Sarcomas, University of Texas MD Anderson Cancer Center
Reineke Schoot, MD, PhD
Princess Máxima Center, Utrecht, The Netherlands
Silvia Stacchiotti, MD
Medical Oncologist, Fondazione IRCCS Istituto Nazionale Dei Tumori
Gabriel Tinoco, MD, MBA
Associate Professor of Medicine, Division of Medical Oncology at The Ohio State University James Cancer Hospital
Keila Torres, MD, PhD
Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Scientific Advisory Board
Aimee Crago, MD, PhD
Assistant Attending Surgeon, Memorial Sloan Kettering Cancer Center
Chair, The DTRF Scientific Advisory Board
Mushriq Al-Jazrawe, PHD
Scientific Director, High Throughput Sciences, Koch Institute for Integrative Cancer Research at MIT
Benjamin Alman, MD
Department Chair, Orthopedic Surgery, Duke University
Jesse Boehm, PhD
Chief Science Officer, Break Through Cancer Principal Investigator, MIT and Broad Institute
Cristabelle De Souza, PhD
Instructor, Department of Radiation Oncology Stanford University
Mrinal Gounder, MD
Associate Professor and Medical Oncologist, Memorial Sloan Kettering Cancer Center
Alessandro Gronchi, MD
Chief of Sarcoma Service, Chair of the Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori (National Cancer Institute) Milan, Italy
Alexander Lazar, MD, PhD
Director, Department of Pathology, The University of Texas MD Anderson Cancer Center Selective (Soft Tissue) Pathology Fellowship Training Program
Kelly Mercier, PhD
Adjunct associate professor at Duke University and Diagnostics Regional Medical Lead for Daiichi Sankyo
Roel Nusse, PhD
Professor of Cancer Research and of Developmental Biology at Stanford University School of Medicine, Program Director of Stanford’s Cancer Stem Cell Research Program, and member of Stanford’s Institute for Stem Cell Biology and Regenerative Medicine
Matt van de Rijn, MD, PhD
Professor, Department of Pathology, Stanford University Medical Center
